Educational Curriculum

Fellows training in our program receive a comprehensive education in the management of malignant and non-malignant hematology, bone marrow transplant, and solid tumor oncology in both the inpatient and outpatient settings.

  • Conferences include:
    • Weekly core curriculum lecture series given by disease specific faculty
    • Fellow presentation conference including in-depth topic presentations, journal clubs and research in progress.
    • Hematology case conference
    • Oncology case conference
    • Disease specific tumor boards (required for area pertaining to continuity clinic).
    • Internal medicine department grand rounds and cancer center grand rounds are strongly encouraged.

Clinical Experience

  • Fellows rotate through one-month inpatient service blocks at Robert Wood Johnson University Hospital, including benign hematology consults, solid tumor oncology consults, hematologic malignancy service, and bone marrow transplant service.
  • Fellows also spend one-month blocks in outpatient hematology and oncology clinic months.
  • Fellows engage in continuity clinics with sub-specialty faculty consisting of a half-day clinic per week occurring in six-month blocks during the 36 month period of fellowship.
  • Inpatient and outpatient rotations and continuity clinics take place at Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, or Robert Wood Johnson University Hospital in New Brunswick, NJ. In addition, fellows spend one month each year in outpatient oncology clinics in Saint Barnabas Medical Center located in Livingston, NJ.

Research:

All fellows are assigned research blocks during their second and third year of training. Fellows are expected to engage in research in any of the areas of hematology or medical oncology , depending on their areas of interest. Research overviews can be found at www.cinj.org/research/research-overview and rwjms.umdnj.edu/tments_institutes/medicine/divisions/hem/research/index.html.

Teaching:

Fellows are able to develop their teaching skills, under supervision and mentorship of the attending faculty, in bedside teaching, small group and conference presentations for medical students and internal medicine residents.

Each fellow is expected to present in-depth topic presentations and journal clubs to their colleagues during the course of each year.

During inpatient service blocks, fellows are engaged in daily teaching rounds.

Noon conference occurs three days per week and includes faculty lectures, educational sessions and board review sessions.

Fellows have weekly hematology topic conference (lecture, journal club or topic presentation), hematology case conference, and oncology case or topic conference.

Fellows routinely attend tumor boards at CINJ (required for area pertaining to continuity clinic).

Attending internal medicine department grand rounds and cancer center grand rounds is strongly encouraged.

Program Resources:

Robert Wood Johnson University Hospital:

Robert Wood Johnson University Hospital (RWJUH), New Brunswick, NJ, is the primary teaching hospital of Rutgers Robert Wood Johnson Medical School. RWJUH consists of 507 medical/surgical beds, accredited residencies in all specialties and subspecialties, and serves as a tertiary care facility for the 2.8 million people living in central New Jersey. The Cancer Hospital of New Jersey is part of RWJUH and includes 103 beds including a medical oncology floor with 31 beds, a hematologic malignancy floor with 20 beds, and a designated Bone Marrow Transplantation Unit with 11 beds.

Ambulatory Clinics:

The Clinical Academic Building, Rutgers Cancer Institute of New Jersey (CINJ), and Saint Barnabas Medical Center provide extensive ambulatory facilities for hematology and oncology outpatient care.

Rutgers Cancer Institute of New Jersey (CINJ): The Rutgers Cancer Institute of New Jersey ( www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. CINJ is a Center of Excellence at Rutgers Robert Wood Johnson Medical School. CINJ offers patients numerous options for clinical trials, including investigator-initiated, industry, and cooperative group studies. To learn more about CINJ, please go to www.cinj.org/about-cinj/about-rutgers-cancer-institute-new-jersey.

CINJ Oncology Programs:

  • Blood and Marrow Transplant Program
  • Brain and Spine Tumor Program
  • Stacy Goldstein Breast Cancer Center
  • Endocrine and Neuroendocrine Tumor Program
  • Gastrointestinal Cancers Program
  • Gynecologic Oncology Program
  • Head and Neck Program
  • Hematologic Malignancies Program
  • Melanoma/Skin Cancer Program
  • Pediatric Hematology/Oncology Program
  • Phase I/Investigational Therapeutics
  • Thoracic Oncology Program
  • Urologic Oncology Program

Hematology Programs:

  • New Jersey Regional Hemophilia Program
  • Thrombosis Program
  • Hematology and Gynecology Program
  • Sickle Cell Program
  • General Hematology Program
  • Pediatric Hemostasis and Thrombosis Program
  • Special Hemostasis Laboratory

Global Oncology Elective Program

This is a non-mandatory elective for fellows to spend at least 1 month at University of Botswana School of Medicine during their 3 year Hematology-Oncology Fellowship. Fellows identify a research project based on Botswana’s needs in cancer care and their professional interest. The objective for their time in Botswana is to gain exposure to Oncologic care in a resource-limited setting and identify a research/quality improvement project that they can remain involved in throughout their remaining research blocks in fellowship. Participating fellows engage in regular seminars and research-related activities.

CINJ Research Programs

  • Cancer Growth and Metabolism
  • Genomic Instability and Cancer Genetics
  • Cancer Pharmacology
  • Clinical Investigations and Precision Therapeutics
  • Cancer Prevention and Control

Hematology Research Programs

  • Hemophilia
  • Von Willebrand disease
  • Other bleeding disorders
  • Cancer and Thrombosis
  • Myelodysplastic syndrome and platelet dysfunction
  • Covid-19 related thrombosis and inflammation, convalescent plasma

Elective Rotations:

  • Hematopathology and Hemostasis Laboratory
  • Radiation Oncology
  • Gynecologic Oncology
  • Transfusion Medicine
  • Precision Medicine
  • Oncology Pharmacy
  • Palliative Care